SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
Sanjay PandanaboyanaJohn MoirJohn S LeedsKofi W OppongAditya KanwarAhmed MarzoukAjay BelgaumkarAjay GuptaAjith K SiriwardenaAli Raza HaqueAltaf AwanAnita BalakrishnanArab RawashdehBogdan IvanovChetan ParmarChristopher M HalloranClifford CaruanaCynthia-Michelle BorgDhanny GomezDimitrios DamaskosDimitrios KaraviasGuy FinchHusam EbiedJames K PineJames R A SkipworthJames MilburnJaved LatifJeyakumar Ratnam ApollosJihène El KafsiJohn A WindsorKeith RobertsKelvin WangKrish RaviMaria V CoatsMarianne HollymanMary PhillipsMichael OkochaMichael Sj WilsonNadeem A AmeerNagappan KumarNehal ShahPierfrancesco LapollaConnor MageeBilal Al-SarirehRaimundas LuneviciusRami BenhmidaRishi SinghalSrinivasan BalachandraSemra Demirli AtıcıShameen JaunooSimon DwerryhouseTamsin BoyceVasileios CharalampakisVenkat KanakalaZaigham AbbasManu K Nayarnull nullPublished in: Gut (2021)
Patients with AP and coexistent SARS-CoV-2 infection are at increased risk of severe AP, worse clinical outcomes, prolonged length of hospital stay and high 30-day mortality.